| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/05/2002 | US20020123042 Detection of loss of the wild-type hubub1 gene |
| 09/05/2002 | US20020122862 Dietetic food composition and dietetic method using such composition |
| 09/05/2002 | US20020122822 Having a friability of less than about 2% from an active ingredient, an excipient in the form of a hydrate, and a water- swellable excipient; and applying energy to decrease the hardness of the tablet by at least 20%. |
| 09/05/2002 | US20020122817 Solid instant-release forms of administration and process for producing the same |
| 09/05/2002 | US20020122802 Diagnosis and treatment of malignant neoplasms |
| 09/05/2002 | US20020122800 Orally applying a mixture of a steroid and an inhibitor of TNF-alpha to treat aphthous |
| 09/05/2002 | US20020122793 Heparinase III and uses thereof |
| 09/05/2002 | US20020122773 Each optionally in the form of the enantiomers, mixtures of the enantiomers or in the form of the racemates; optionally hydrates or solvates |
| 09/05/2002 | DE10109763A1 Pharmazeutische Salze Pharmaceutical Salts |
| 09/05/2002 | DE10107659A1 Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin Mucoadhesive disintegratable pharmaceutical preparation for drug delivery in veterinary and human medicine |
| 09/05/2002 | DE10106718A1 Hefestamm von Saccharomyces cerevisiae mit funktioneller Expression eines Glut-Transporters Yeast strain of Saccharomyces cerevisiae with functional expression of Glut-transporter |
| 09/04/2002 | EP1236800A2 Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1236720A1 Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors |
| 09/04/2002 | EP1236475A2 Combination therapy for osteoporosis consisting of an estrogen agonist/antagonist and a growth hormone secretagogue |
| 09/04/2002 | EP1236173A2 Methods and devices for identifying patterns in biological systems |
| 09/04/2002 | EP1236046A2 Methods for screening compounds active on neurons |
| 09/04/2002 | EP1236044A2 Diagnosing and treating arthritic disorders |
| 09/04/2002 | EP1235933A2 Mammalian toxicological response markers |
| 09/04/2002 | EP1235925A1 Feeding assay for identifying nematicidal compounds |
| 09/04/2002 | EP1235907A1 6 human secreted proteins |
| 09/04/2002 | EP1235860A2 G-protein coupled receptors |
| 09/04/2002 | EP1235843A1 26 human secreted proteins |
| 09/04/2002 | EP1235834A1 (1r,cis)-4-(4-amino-7h-pyrr0l0[2,3- i(d)]pyrimidine-7-yl)-2-cyclopentene-1-methanol derivatives as antiviral |
| 09/04/2002 | EP1235830A2 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 09/04/2002 | EP1235825A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 09/04/2002 | EP1235814A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 09/04/2002 | EP1235598A2 Compositions of a combination of radioactive therapy and cell-cycle inhibitors |
| 09/04/2002 | EP1235596A2 Use of lytic toxins and toxin conjugates |
| 09/04/2002 | EP1235594A2 Inhibition of secretion from non-neuronal cells |
| 09/04/2002 | EP1235593A2 Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith |
| 09/04/2002 | EP1235592A1 COMBINATION OF COMPOUNDS THAT INHIBIT THE BIOLOGICAL EFFECTS OF TNF-$g(a) AND CD95L IN A MEDICAMENT |
| 09/04/2002 | EP1235580A2 Transdermal system containing acetylsalicylic acid for treatment of migraine |
| 09/04/2002 | EP1235576A2 Combinations of sumatriptan or naratriptan with cyclooxygenase ii inhibitor |
| 09/04/2002 | EP1235575A2 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
| 09/04/2002 | EP1235570A2 Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics |
| 09/04/2002 | EP1235569A2 Medicament and combination of compatible medicaments |
| 09/04/2002 | EP1235568A2 Depletion of cellular coenzyme-a levels as a means to selectively kill cancer cells |
| 09/04/2002 | EP1235565A1 Use of 5ht 3 agonists for relaxing the fundus |
| 09/04/2002 | EP1235563A2 Use of anti(w)pressor agents for vascular remodeling in genital dysfunction |
| 09/04/2002 | EP1049478B1 Composition containing propargylamine for enhancing cancer therapy |
| 09/04/2002 | EP0934528B1 A method for the identification of compounds with anxiolytic potential |
| 09/04/2002 | EP0896615B1 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator |
| 09/04/2002 | EP0801574A4 Modulation of integrin-mediated signal transduction |
| 09/04/2002 | EP0783884B1 Conagenin as preventive and remedy for diarrhea |
| 09/04/2002 | EP0750515B1 Low molecular weight hyaluronic acid with peptide or protein |
| 09/04/2002 | EP0738107B1 Inhibitors of fatty acid synthesis as antimicrobial agents |
| 09/04/2002 | CN1367845A Parallel ligand index concentration system generating method |
| 09/04/2002 | CN1367830A Cancer associated antigens and uses therefor |
| 09/04/2002 | CN1367829A Compositions and methods for therapy and diagnosis of lung cancer |
| 09/04/2002 | CN1367790A Moraxella cattarrhalis BASB114 polypeptide antigens and uses thereof |
| 09/04/2002 | CN1367700A Small peptides and method for downregulation of lgE |
| 09/04/2002 | CN1367697A Therapeutical method for improving cognition |
| 09/04/2002 | CN1367693A Pharmaceutical compositions containing poly(ADP-ribose) glycohydrolase inhibitors and method of using the same |
| 09/04/2002 | CN1367691A New use of taxoid derivatives |
| 09/04/2002 | CN1367690A Combination therapy using pentafluorobenzenesulfonamide |
| 09/04/2002 | CN1367689A Utilisation of inhibitors of sodium hydrogen exchanger for producing medicament for preventing organ dysfunctions and diseases related to particular age and for prolonging life |
| 09/04/2002 | CN1367688A Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to graft |
| 09/04/2002 | CN1367687A Calcilytic compounds |
| 09/04/2002 | CN1367686A Novel compositions |
| 09/04/2002 | CN1367684A Method and composition for treating solid tumors |
| 09/04/2002 | CN1367680A Pre-formed gel sheet |
| 09/04/2002 | CN1090187C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS |
| 09/04/2002 | CN1090186C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS |
| 09/04/2002 | CN1090031C Novel use of ACE-inhibitor for treatment of dyspeptic symptoms |
| 09/04/2002 | CN1090030C Complex cow's milk gamma globulin and making method thereof |
| 09/04/2002 | CN1090022C Cancer treatment by photodynamic therapy, in combination with immunoadjuvant |
| 09/04/2002 | CN1090021C Preparation method and use of sulfated oligosaccharides |
| 09/03/2002 | US6444802 Human aminopeptidase |
| 09/03/2002 | US6444697 Synthetic compounds for treatment of inflammation |
| 09/03/2002 | US6444665 Method for treating pain |
| 09/03/2002 | US6444657 2-(phosphonomethyl)pentanedioic acid; 2-(2-sulfanylethyl) pentanedioic acid; epithelial tissue scarring, collagen vascular disease, fibroproliferation, connective tissue disorder, respiratory distress syndrome; tgf regulator |
| 09/03/2002 | US6444646 Use of angiotensin II type 2 receptor agonists in tissue repair |
| 09/03/2002 | US6444644 Peptide having specified amino acid sequence; used for inhibition of thromboplastin |
| 09/03/2002 | US6444642 Administering to mammal effective amount of neuregulin polypeptide with p185.sup.erbb2 protein binding activity to stimulate myogenesis of muscle cells |
| 09/03/2002 | US6444434 Compounds inhibiting the activation of fx to fxa by tf/fviia. the compounds are anticoagulants. the invention also relates to a method of identifying a drug candidate. |
| 09/03/2002 | US6444431 Angiostatin receptor |
| 09/03/2002 | US6444218 Soft chewable multivitamin tablet comprising separated active ingredients |
| 09/03/2002 | US6444210 Bacterial and synthetic polysaccharide immunomodulators that enhance general immunity |
| 09/03/2002 | US6444208 Ribonuclease III from Streptococcus pneumoniae |
| 09/03/2002 | US6444201 Therapy for nervous system disorders |
| 09/01/2002 | CA2373596A1 Combination treatment for depression, obsessive compulsive disorder, and psychosis |
| 09/01/2002 | CA2356201A1 Compounds and compositions for delivering active agents |
| 08/29/2002 | WO2002066978A2 Detection of compounds that modulate inflammatory responses |
| 08/29/2002 | WO2002066681A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 08/29/2002 | WO2002066647A2 Type 2 ctokine receptor and nucleic acids encoding same |
| 08/29/2002 | WO2002066646A2 Neurotransmission-associated proteins |
| 08/29/2002 | WO2002066624A2 Novel human protease and polynucleotides encoding the same |
| 08/29/2002 | WO2002066617A1 Method for detecting a risk of hypertension and uses thereof |
| 08/29/2002 | WO2002066602A2 Detection of allergen-specific ige |
| 08/29/2002 | WO2002066512A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/29/2002 | WO2002066509A2 Treatment involving dkk-1 or antagonists thereof |
| 08/29/2002 | WO2002066469A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066468A2 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/29/2002 | WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066427A2 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 08/29/2002 | WO2002066422A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 08/29/2002 | WO2002066068A2 Method of treating neurological diseases |
| 08/29/2002 | WO2002066062A2 Enhancement of glp-2 activity |
| 08/29/2002 | WO2002066061A1 Active oxygen generator containing photosensitizer for ultrasonic therapy |